Aortic Pseudoaneurysm Formation Following Concurrent Chemoradiotherapy and Metallic Stent Insertion in a Patient with Esophageal Cancer

7Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Aortic pseudoaneurysm formation subsequent to concurrent chemoradiotherapy (CCRT) for esophageal cancer patient with esophageal metallic stent insertion is a rare condition. A 52-year-old man with esophageal cancer, cT4N1M0, stage IIIC, was treated with concurrent weekly cisplatin (30 mg/m2) and 5-Fluorouracil (500 mg/m2) as well as radiotherapy (50.4 Gy in 28 fractions) for 6 weeks. An esophageal metallic stent was inserted for dysphagia 1 week after initiation of CCRT. During the treatment regimen, the platelet count dropped to less than 200×103/μL. One month after the completion of CCRT, chest CT revealed the presence of an aortic pseudoaneurysm as well as aortoesophageal fistulas. A thoracic aortic endografting was performed and the patient responded well to surgery. However, the patient died 2 months later due to a nosocomial infection. Multimodality treatment for esophageal cancer comprising cisplatin- based CCRT and esophageal metallic stent placement near a great vessel may increase the risk of pseudoaneurysm formation.

Cite

CITATION STYLE

APA

Hou, P. Y., Teng, C. J., Chung, C. S., Liu, C. Y., Huang, C. C., Chang, M. H., … Hsieh, C. H. (2015). Aortic Pseudoaneurysm Formation Following Concurrent Chemoradiotherapy and Metallic Stent Insertion in a Patient with Esophageal Cancer. Medicine (United States), 94(20). https://doi.org/10.1097/MD.0000000000000862

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free